Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03756688 · ClinicalTrials.gov registry record · NA
Penile Length Restoration in Men With Diabetes Mellitus, Type II
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT03756688: Completed NA study, sponsored by Mayo Clinic.
NCT03756688 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03756688, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The objective of the current study is to evaluate the efficacy of a novel penile traction device in restoring lost penile length in men with type 2 diabetes.
Interventions
- DEVICE RestoreX PTT - 6 months
- DEVICE RestoreX PTT - 3 months
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2018-11-07 |
| Est. Completion | 2021-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03756688
The ClinicalTrials.gov registry entry for NCT03756688 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which RestoreX PTT - 6 months is the first listed.
NCT03756688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03756688 about?
NCT03756688 is a clinical study titled "Penile Length Restoration in Men With Diabetes Mellitus, Type II". The objective of the current study is to evaluate the efficacy of a novel penile traction device in restoring lost penile length in men with type 2 diabetes.
What is the current status of trial NCT03756688?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2018-11-07. Estimated completion is 2021-03-18.
What interventions are being tested in trial NCT03756688?
The interventions under investigation include: RestoreX PTT - 6 months (DEVICE), RestoreX PTT - 3 months (DEVICE).
Who is sponsoring clinical trial NCT03756688?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.